Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 685 Cholangiocarcinoma 113 Biliary Tract Neoplasms 95 Neoplasms 69 Neoplasm Metastasis 66 Gallbladder Neoplasms 61 Colorectal Neoplasms 49 Bile Duct Neoplasms 40 Carcinoma, Non-Small-Cell Lung 37 Adenocarcinoma 28 Carcinoma, Hepatocellular 26 Stomach Neoplasms 22 Liver Neoplasms 21 Colonic Neoplasms 21 Ovarian Neoplasms 20 Lung Neoplasms 19 Breast Neoplasms 18 Rectal Neoplasms 15 Carcinoma, Pancreatic Ductal 15 Pancreatic Adenocarcinoma 13 Esophageal Neoplasms 13 Sarcoma 12 Carcinoma 11 Small Cell Lung Carcinoma 10 Urinary Bladder Neoplasms 9 Gastrointestinal Neoplasms 9 Advanced Pancreatic Cancer 9 Triple Negative Breast Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Recurrence 8

Interventions

Diathermy 6 Fluorouracil 4 Radiotherapy 3 Melphalan 2 Drug Therapy 2 Capecitabine 2 tislelizumab 1 spartalizumab 1 Radiation 1 Oxaliplatin 1 Mitomycin 1 Leucovorin 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Gemcitabine 1 Folfox protocol 1 Floxuridine 1 Cytoreduction Surgical Procedures 1 Control Groups 1 Consolidation Chemotherapy 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Gemcitabine × Gastrointestinal × Clear all

NCT01077427 2017-11-17

HEAT

Klinikum der Universitaet Muenchen, Grosshadern

Phase 3 Unknown

Gastrointestinal

Hyperthermia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡